Guizhou Sanli Pharmaceutical Co.,Ltd.’s Net Profit Rose 68.5% in First Half of 2023

Guizhou Sanli Pharmaceutical Co.,Ltd. (贵州三力制药股份有限公司) (603439.SH) reported a net profit of 100.2 million yuan in the first half of 2023, up 68.5% year-on-year.

Meanwhile, the company posted 630.7 million yuan in revenue, up 46.7% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 533.3 million yuan in total liabilities, with a liability-to-asset ratio of 27.9%.